Kumar Neil
Reporting owner on Forms 3, 4 and 5, CIK 1742485.
Kumar Neil reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| BBIO · BridgeBio Pharma, Inc.CIK 1743881 | director, officer (Chief Executive Officer) | 2 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-19 | S sold | -8,500 | $78.3503 | 477,186 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-19 | S sold | -1,500 | $79.293 | 475,686 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-18 | S sold | -4,490 | $76.9916 | 273,817 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-18 | S sold | -30,490 | $77.8271 | 243,327 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-18 | S sold | -1,277 | $76.9915 | 494,409 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-18 | S sold | -8,723 | $77.8269 | 485,686 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Common Stock, holding | 750,000 | Form 4 | ||||
| BBIO · BridgeBio Pharma, Inc.Common Stock, holding | 3,568,447 | Form 4 | ||||
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-16 | M exercised | +33,544 | 276,871 | Form 4 | |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-16 | M exercised | +19,599 | 296,470 | Form 4 | |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-16 | M exercised | +11,554 | 308,024 | Form 4 | |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-16 | M exercised | +6,519 | 314,543 | Form 4 | |
| BBIO · BridgeBio Pharma, Inc.Common Stock | 2026-11-16 | F withheld for tax | -36,236 | $77.36 | 278,307 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Common Stock, holding | 495,686 | Form 4 | ||||
| BBIO · BridgeBio Pharma, Inc.Common Stock, holding | 750,000 | Form 4 | ||||
| BBIO · BridgeBio Pharma, Inc.Common Stock, holding | 3,568,447 | Form 4 | ||||
| BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative | 2026-11-16 | M exercised | -33,544 | $0 | 33,544 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative | 2026-11-16 | M exercised | -19,599 | $0 | 97,997 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative | 2026-11-16 | M exercised | -11,554 | $0 | 103,984 | Form 4 |
| BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative | 2026-11-16 | M exercised | -6,519 | $0 | 84,755 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001743881-26-000045 | BridgeBio Pharma, Inc. | 2026-11-20 | ||
| Form 4 0001743881-26-000039 | BridgeBio Pharma, Inc. | 2026-11-18 |